FIGURE 6.
Median progression‐free survival (a, c) and meidan overall survival (b, d) curves of patients stratified according to neutrophil‐to‐lymphocyte ratio 2 (NLRT2) and immune‐related adverse events.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.